About this item:

170 Views | 109 Downloads

Author Notes:

Correspondence: Zubair M. Ahmed, Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine University of Maryland, 800 West Baltimore Street, Room 404, Baltimore, MD 21201, USA; zmahmed@som.umaryland.edu

Or: Ali M. Waryah, Medical Research Center, Liaquat University of Medical & Health Sciences, Jamshoro, 76090, Sindh, Pakistan; aliwaryah@lumhs.edu.pk

The authors thank the participating patients and their families, as well as the health care professionals involved in the patient care; Sairah Yousaf for technical assistance; Haris Rapjut for assistance with the ERGs; and Mariya Ahmed and Dimitria Gomes for constructive comments on the manuscript.

Disclosures: none to declare.

Subjects:

Research Funding:

Supported by Higher Education Commission of Pakistan NRPU Grant 2835 to AMW.

This study was also supported by National Institutes of Health: National Institute on Deafness and Other Communication Disorders Grant R01DC016295 (to ZMA) and National Institute of General Medical Sciences Grant R35GM122568 (to RAK and CS).

JAS is funded by Kidney Research UK and the Northern Counties Kidney Research Fund.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Ophthalmology
  • ARL3
  • cone rod dystrophy
  • retinitis pigmentosa
  • autosomal recessive
  • Retinal degeneration
  • Trafficking
  • Mutations
  • GTPASE
  • RP2
  • Proteins
  • Genes

Homozygous Variant in ARL3 Causes Autosomal Recessive Cone Rod Dystrophy

Show all authors Show less authors

Journal Title:

Investigative Ophthalmology & Visual Science

Volume:

Volume 60, Number 14

Publisher:

, Pages 4811-4819

Type of Work:

Article | Final Publisher PDF

Abstract:

PURPOSE: Cone rod dystrophy (CRD) is a group of inherited retinopathies characterized by the loss of cone and rod photoreceptor cells, which results in poor vision. This study aims to clinically and genetically characterize the segregating CRD phenotype in two large, consanguineous Pakistani families. METHODS: Funduscopy, optical coherence tomography (OCT), electroretinography (ERG), color vision, and visual acuity assessments were performed to evaluate the retinal structure and function of the affected individuals. Exome sequencing was performed to identify the genetic cause of CRD. Furthermore, the mutation’s effect was evaluated using purified, bacterially expressed ADP-ribosylation factor-like protein 3 (ARL3) and mammalian cells. RESULTS: Fundus photography and OCT imaging demonstrated features that were consistent with CRD, including bull’s eye macular lesions, macular atrophy, and central photoreceptor thinning. ERG analysis demonstrated moderate to severe reduction primarily of photopic responses in all affected individuals, and scotopic responses show reduction in two affected individuals. The exome sequencing revealed a novel homozygous variant (c.296G>T) in ARL3, which is predicted to substitute an evolutionarily conserved arginine with isoleucine within the encoded protein GTP-binding domain (R99I). The functional studies on the bacterial and heterologous mammalian cells revealed that the arginine at position 99 is essential for the stability of ARL3. CONCLUSIONS: Our study uncovers an additional CRD gene and assigns the CRD phenotype to a variant of ARL3. The results imply that cargo transportation in photoreceptors as mediated by the ARL3 pathway is essential for cone and rod cell survival and vision in humans.

Copyright information:

© 2019 The Authors.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Export to EndNote